With its 80-year record of impeccable quality, Cipla is a trusted name in over 170 countries. Cipla’s extensive range of pharmaceutical and personal care products have brought health and happiness to millions of people all over the world – combining technology and quality with affordability.
Exports for the financial year ended August 31, 2009 amounted to more than Rs. 28,900 million. Cipla exports prescription drugs , raw materials, intermediates, OTC products and veterinary products. Cipla also offers technology for products and processes.
Cipla’s manufacturing facilities have been approved by the following regulatory authorities:

• Food and Drug Administration (FDA), USA
• Medicines and Healthcare products Regulatory Agency (MHRA), UK
• Pharamaceutical Inspection Convention (PIC), Germany
• World Health Organisation (WHO) Department of Health, Canada
• Therapeutic Goods Administration (TGA), Australia
• Medicines Control Council (MCC), South Africa
• National Institute of Pharmacy (NIP), Hungary
• State Institute for the Control of Drugs, Slovak Republic ANVISA, Brazil

Cipla products are bought by over 170 countries located in the following regions: